WHO recommends 2 new COVID treatments

DMCA / Correction Notice
- Advertisement -

World Health Organization (WHO) announced Friday That it has recommended two new drugs for the treatment of COVID.

- Advertisement -

Why this matters: The recommendations come as Cases rise around the world, and may particularly serve low-income countries that have struggled to contain the disease because of a lack of vaccines and other medical needs.

Description: The WHO strongly recommends baricitinib, an oral drug commonly used to treat rheumatoid arthritis, for patients with severe or severe symptoms. It is recommended to administer it along with corticosteroids.

  • The WHO is also conditionally recommending the use of the monoclonal antibody drug sotrovimab for the treatment of mild or moderate symptoms in patients at high risk of hospitalization, including those who are older, immunocompromised and asymptomatic. Huh.
  • “The extent to which these drugs will save lives depends on how widely available and affordable they are,” the organization said in a release.
  • The recommendations are based on evidence from seven trials involving more than 4,000 patients who exhibited a wide range of COVID symptoms.

Noteworthy: WHO said it is working to “secure global supply capacity and equitable and sustainable access to newly recommended therapeutics”.


- Advertisement -

Stay on top - Get the daily news in your inbox

Recent Articles

Related Stories